Literature DB >> 10886718

Dissociation of interleukin-4 and interleukin-5 production following treatment for Schistosoma haematobium infection in humans.

J T Scott1, C m Turner, F Mutapi, M E Woolhouse, S K Chandiwana, T Mduluza, P D Ndhlovu, P Hagan.   

Abstract

Infection with Schistosoma haematobium, the causative agent of urinary schistosomiasis is characterized by high levels of specific immunoglobulin (Ig) E and eosinophilia. The primary cytokines driving production of IgE and eosinophilia are IL-4 and IL-5, respectively. In this study, IL-4 and IL-5 production in children from a schistosome endemic area of Zimbabwe were investigated. Blood samples were taken, stimulated in vitro with either mitogen or schistosome antigens and assayed for IL-4 and IL-5 production. These samples produced either IL-4 or IL-5 but rarely both cytokines when blood was cultured in vitro for 24 or 48 h. After 72 h culture in vitro, both cytokines were detected in most samples. These data imply that while IL-4 and IL-5 are both produced by schistosome infected people, they are not necessarily coproduced.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886718     DOI: 10.1046/j.1365-3024.2000.00311.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  11 in total

1.  Cytokine production in Ancylostoma duodenale infection.

Authors:  Shaimaa Abdulhussein Shlash; Zubaida Falih Alzubaidi; Huda Ali Saleh
Journal:  J Med Life       Date:  2022-04

2.  Regulatory and activated T cells in human Schistosoma haematobium infections.

Authors:  Norman Nausch; Nicholas Midzi; Takafira Mduluza; Rick M Maizels; Francisca Mutapi
Journal:  PLoS One       Date:  2011-02-10       Impact factor: 3.240

3.  Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status.

Authors:  T Milner; L Reilly; N Nausch; N Midzi; T Mduluza; R Maizels; F Mutapi
Journal:  Parasite Immunol       Date:  2010 Nov-Dec       Impact factor: 2.280

Review 4.  Acquired immune heterogeneity and its sources in human helminth infection.

Authors:  C D Bourke; R M Maizels; F Mutapi
Journal:  Parasitology       Date:  2010-10-15       Impact factor: 3.234

Review 5.  Immunology of human schistosomiasis.

Authors:  D G Colley; W E Secor
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

6.  Cytokine profiles of Necator americanus and Plasmodium falciparum co-infected patients in rural Ghana.

Authors:  Benjamin Amoani; Bright Adu; Margaret T Frempong; Tracy Sarkodie-Addo; Samuel Victor Nuvor; Emmanuel Kwasi Abu; Lisa M Harrison; Michael Cappello; Ben Gyan; Michael D Wilson
Journal:  Cytokine X       Date:  2019-10-04

Review 7.  Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings.

Authors:  Emmanuella Driciru; Jan Pieter R Koopman; Stephen Cose; Afzal A Siddiqui; Maria Yazdanbakhsh; Alison M Elliott; Meta Roestenberg
Journal:  Front Immunol       Date:  2021-03-04       Impact factor: 7.561

8.  Effect of hookworm infection and anthelmintic treatment on naturally acquired antibody responses against the GMZ2 malaria vaccine candidate and constituent antigens.

Authors:  Benjamin Amoani; Ben Gyan; Samuel Asamoah Sakyi; Emmanuel Kwasi Abu; Samuel Victor Nuvor; Precious Barnes; Tracy Sarkodie-Addo; Benjamin Ahenkorah; Christian Sewor; Duah Dwomoh; Michael Theisen; Michael Cappello; Michael D Wilson; Bright Adu
Journal:  BMC Infect Dis       Date:  2021-04-08       Impact factor: 3.090

9.  Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses.

Authors:  L Reilly; C Magkrioti; T Mduluza; D R Cavanagh; F Mutapi
Journal:  BMC Infect Dis       Date:  2008-11-17       Impact factor: 3.090

10.  Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with age.

Authors:  Francisca Mutapi; Georgina Winborn; Nicholas Midzi; Matthew Taylor; Takafira Mduluza; Rick M Maizels
Journal:  BMC Infect Dis       Date:  2007-11-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.